Edwards Lifesciences Corp Stock Market Value
| EW Stock | USD 76.34 2.99 3.77% |
| Symbol | Edwards |
What growth prospects exist in Health Care Equipment & Supplies sector? Can Edwards capture new markets? Factors like these will boost the valuation of Edwards Lifesciences. Projected growth potential of Edwards fundamentally drives upward valuation adjustments. Valuation analysis balances hard financial data with qualitative growth assessments. While each Edwards Lifesciences valuation metric matters, prioritizing which indicators carry greater predictive weight remains essential.
Quarterly Earnings Growth (0.90) | Earnings Share 2.35 | Revenue Per Share | Quarterly Revenue Growth 0.147 | Return On Assets |
Investors evaluate Edwards Lifesciences Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Edwards Lifesciences' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investment professionals apply varied valuation frameworks to compute inherent worth and acquire positions when market prices trade at discounts to calculated value. External factors like market trends, sector rotation, and investor psychology can cause Edwards Lifesciences' market price to deviate significantly from intrinsic value.
It's important to distinguish between Edwards Lifesciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Edwards Lifesciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Edwards Lifesciences' market price signifies the transaction level at which participants voluntarily complete trades.
Edwards Lifesciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Edwards Lifesciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Edwards Lifesciences.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Edwards Lifesciences on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Edwards Lifesciences Corp or generate 0.0% return on investment in Edwards Lifesciences over 90 days. Edwards Lifesciences is related to or competes with Becton Dickinson, Cardinal Health, Bruker, Argenx NV, Veeva Systems, Agilent Technologies, and STERIS Plc. Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and ... More
Edwards Lifesciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Edwards Lifesciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Edwards Lifesciences Corp upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 5.33 | |||
| Value At Risk | (2.24) | |||
| Potential Upside | 2.33 |
Edwards Lifesciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Edwards Lifesciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Edwards Lifesciences' standard deviation. In reality, there are many statistical measures that can use Edwards Lifesciences historical prices to predict the future Edwards Lifesciences' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.22) | |||
| Treynor Ratio | (0.09) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Edwards Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Edwards Lifesciences February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.08) | |||
| Mean Deviation | 1.07 | |||
| Coefficient Of Variation | (2,706) | |||
| Standard Deviation | 1.34 | |||
| Variance | 1.79 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.22) | |||
| Treynor Ratio | (0.09) | |||
| Maximum Drawdown | 5.33 | |||
| Value At Risk | (2.24) | |||
| Potential Upside | 2.33 | |||
| Skewness | 0.0769 | |||
| Kurtosis | (0.43) |
Edwards Lifesciences Corp Backtested Returns
Edwards Lifesciences Corp secures Sharpe Ratio (or Efficiency) of -0.0955, which denotes the company had a -0.0955 % return per unit of risk over the last 3 months. Edwards Lifesciences Corp exposes twenty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Edwards Lifesciences' Mean Deviation of 1.07, variance of 1.79, and Standard Deviation of 1.34 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.66, which means possible diversification benefits within a given portfolio. As returns on the market increase, Edwards Lifesciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Edwards Lifesciences is expected to be smaller as well. At this point, Edwards Lifesciences Corp has a negative expected return of -0.13%. Please make sure to confirm Edwards Lifesciences' total risk alpha and rate of daily change , to decide if Edwards Lifesciences Corp performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.39 |
Poor reverse predictability
Edwards Lifesciences Corp has poor reverse predictability. Overlapping area represents the amount of predictability between Edwards Lifesciences time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Edwards Lifesciences Corp price movement. The serial correlation of -0.39 indicates that just about 39.0% of current Edwards Lifesciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.39 | |
| Spearman Rank Test | -0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 6.8 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Edwards Stock Analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.